The circulating level of this antigen has proved to be a reliable predictor of disease activity in patients with ovarian carcinoma. In breast cancer, serum levels of a number of antigens, incluiding CA 125, carcinoembryonic antigen (CEA), and CA 15-3, have been studied as biomarkers for disease activity.